Search

Your search keyword '"Takahiro Tsuchikawa"' showing total 264 results

Search Constraints

Start Over You searched for: Author "Takahiro Tsuchikawa" Remove constraint Author: "Takahiro Tsuchikawa"
264 results on '"Takahiro Tsuchikawa"'

Search Results

1. Distinct clinicopathological features of neuroendocrine liver metastases originating from the pancreas and rectum

2. Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients

3. Delphi Method Consensus-Based Identification of Primary Trauma Care Skills Required for General Surgeons in Japan

4. Laparoscopic real-time vessel navigation using indocyanine green fluorescence during the laparoscopic-Warshaw technique: First clinical experience

5. Laparoscopic-assisted distal gastrectomy and central pancreatectomy for gastric and perigastric lymph node metastases and pancreatic invasion from melanoma: a case report

6. Laparoscopic partial splenectomy for splenic lymphangioma: a case report

7. Metachronous liver metastases after long-term follow-up of endoscopic resection for rectal neuroendocrine neoplasms: a report of three cases

8. The effect of the body mass index on the short-term surgical outcomes of laparoscopic total gastrectomy: A propensity score-matched study

9. Treatment of bleeding from a portion of pancreatojejunostomy after pancreaticoduodenectomy with division of the splenic vein: two case reports

10. Central pancreatic body-preserving pancreatoduodenectomy for pancreatic head cancer following a combined total gastrectomy and distal pancreatectomy: a case report

11. Simultaneous surgical treatment for esophagogastric junctional cancer and splenic artery aneurysm resection with spleen preservation using fluorescence imaging: a case report

12. Metastatic mixed adenoneuroendocrine carcinoma of the liver successfully resected by hepatic trisectionectomy following chemotherapy: A case report

13. The surgical outcome of minimally invasive pharyngo-laryngo-oesophagectomy in prone position

14. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report

15. Primary malignant melanoma of the esophagus treated with subtotal esophagectomy: a case report

16. Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma.

17. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma

18. Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma

19. ASO Visual Abstract: Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma After Pancreatectomy—TP53 and SMAD4 Mutation Scoring in Combination with CA19-9

20. Supplemental Table 4 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

21. Supplemental figure 5 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

22. Supplemental figure 2 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

23. Supplemental figure 4 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

24. Supplemental figure 1 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

25. Supplemental figure 3 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

26. Supplemental Table 3 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

27. Supplemental Table 2 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

28. Supplemental Table 5 from Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

29. Supplementary Figure 1 from Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

31. Supplementary Figure 2 from Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

33. Supplementary Table 1A-C from Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

34. Supplementary Figure 5 from Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

35. Supplemental Figure Legends from Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

36. Supplementary Figure 4 from Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

37. Supplementary Figure 3 from Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

41. Data from Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

42. CCR7 Mediates Cell Invasion and Migration in Extrahepatic Cholangiocarcinoma by Inducing Epithelial–Mesenchymal Transition

43. Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy

44. Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9

45. Outcomes of laparoscopic total gastrectomy in elderly patients: a propensity score matching analysis

47. Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker

48. The assessment of risk factors for postoperative delirium using cubic spline curves in gastroenterological surgery

49. Retroviral Replicating Vector Toca 511 (

50. Retroviral Replicating Vector Toca 511 (vocimagene amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer

Catalog

Books, media, physical & digital resources